FTC Issues Long-Awaited Revised "Green Guides"
Client Alert | 1 min read | 10.01.12
Today the Federal Trade Commission (FTC) issued its latest revisions to the Guides for the Use of Environmental Marketing Claims, 16 CFR Part 260, commonly referred to as the "Green Guides." These long-awaited changes to the Green Guides follow proposed revisions published in October 2010 and trail fourteen years after the FTC's last revision of the Green Guides in 1998. Information about the changes, including the FTC's press release, the Federal Register Notice, and a summary of the proposed changes, is available on the FTC's website here.
The Revised Green Guides differ from the 2010 proposed revisions in some respects, accounting for the many comments the FTC received about those proposed revisions. The Revised Green Guides amend the FTC's environmental marketing claims guidance last published in 1998 including specific new guidance regarding general environmental benefit claims; certificates and seals of approval; the use of "free of" and non-toxic labels; and compostable, degradable, recyclable, and refillable claims. The guides also address claims made about carbon offsets, renewable energy, renewable materials, and source reduction.
For more information about the Revised Green Guides, as well as a forthcoming substantive analysis of the revisions, please contact Crowell & Moring.
Insights
Client Alert | 5 min read | 02.23.26
UK Government Seeks Evidence on Ownership and Control in Financial Sanctions Regulations
The UK’s Office of Financial Sanctions Implementation (OFSI) has launched a call for evidence concerning the "ownership and control" test within UK financial sanctions. The call for evidence, running until 11:59 p.m. on 13 April 2026, seeks stakeholder views on the challenges and implementation of the "control" limb, with particular focus on its hypothetical element.
Client Alert | 4 min read | 02.20.26
Client Alert | 7 min read | 02.20.26
Section 5949 Proposed Rule Puts the FAR Council's Chips on the Table
Client Alert | 5 min read | 02.20.26
Trump Administration Pursues MFN Pricing for Prescription Drugs
